Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: A phase II trial (CALGB 8944).
Breast Cancer Research and Treatment.
Times cited: 12
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
Journal of Clinical Oncology.
Times cited: 16
Combination trial of subcutaneous recombinant α2b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma.
Medical and Pediatric Oncology.
Times cited: 13